Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC).
about
LC-MS/MS assay of quinapril and its metabolite quinaprilat for drug bioequivalence evaluation: prospective, concurrential and retrospective method validation.Hptlc method development and validation of trandolapril in bulk and pharmaceutical dosage forms.Simultaneous Determination of Acetaminophen and Synthetic Color(s) by Derivative Spectroscopy in Syrup Formulations and Validation by HPLC: Exposure Risk of Colors to Children.Validated HPTLC Method for Simultaneous Determination of Quinapril Hydrochloride and Hydrochlorothiazide in a Tablet Dosage Form.Stability-indicating Reversed-phase Liquid Chromatographic Method for Simultaneous Determination of Losartan Potassium and Ramipril in Tablets.Simultaneous determination of retinoic acid and hydroquinone in skin ointment using spectrophotometric technique (ratio difference method).Preparation, characterization, and analytical application of ramipril membrane-based ion-selective electrode.Determination of mirtazapine in spiked human plasma and tablets by first derivative spectrofluorimetric method.Stability-indicating methods for the determination of mosapride citrate in the presence of its degradation products according to ICH guidelines.Green micellar HPLC analysis of three angiotensin-converting enzyme inhibitors in their mixtures with hydrochlorothiazide and modeling of their retention behavior by fitting to Foley's model.A smart simple spectrophotometric method for simultaneous determination of binary mixtures.Development and validation of an rp-hplc method for simultaneous determination of Ramipril and Amlodipine in tablets.Determination of a novel ACE inhibitor in the presence of alkaline and oxidative degradation products using smart spectrophotometric and chemometric methods.
P2860
Q33448621-229C88A5-8501-46B5-BC3D-B78EC1613A9EQ40304652-5DE24A34-46DF-4FA0-8F18-6D3984703DACQ41110194-6AD69188-DF31-49AF-A966-4C4D1AB4C083Q42095057-74B50D0A-4D7B-4538-AFF8-D51B27BB1D1FQ42176022-EA6A4B72-CAD8-4C79-9F2A-2F15E986C70FQ42556996-3A269F85-5B64-45AE-813B-12B1A4DAB1CBQ42926413-3329EF54-3C3E-465C-A8C7-2C8F38D90BD7Q43064592-96771D18-BB2D-4689-8A74-C8AFD5D9AEF2Q46412429-9A463E31-B33A-4D4B-9991-8D5EE5547706Q48103040-F66B1495-3AD3-4696-93F6-B51F97B32CBDQ49181684-BE9E6C84-25CE-4A15-AC08-88C111EEE801Q49622397-F9D5BD50-1C94-424D-B692-EAA5DB848CD9Q50116664-A351E55D-0523-4E84-855B-971748B9ABB7
P2860
Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC).
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Analysis of ACE inhibitors in ...... liquid chromatography (HPLC).
@en
type
label
Analysis of ACE inhibitors in ...... liquid chromatography (HPLC).
@en
prefLabel
Analysis of ACE inhibitors in ...... liquid chromatography (HPLC).
@en
P1476
Analysis of ACE inhibitors in ...... d liquid chromatography (HPLC)
@en
P2093
P304
P356
10.1016/S0731-7085(97)00075-7
P577
1997-11-01T00:00:00Z